GLP-1 drugs: what Alaska Medicaid paid

Alaska Medicaid shows a published payment figure for 5 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Alaska Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Alaska Medicaid’s payment record shows

In 2026Q1, the product Alaska Medicaid paid for most often was Ozempic®, at 3,498 prescriptions¹⁹ of the 5,075 to 5,183^1,7,19,25,43 across all 8 products, or 69 percent of the published count.

Alaska Medicaid itself reimbursed at least $4,889,981 for these products in the quarter, about $966 per prescription. Pharmacies were paid $4,991,824 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Zepbound®, at about $1,051.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Alaska Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Alaska Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Alaska Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Alaska Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Fee-for-service	880¹	17%	$925,080	$937,774	$1,051
tirzepatideMounjaro®	Fee-for-service	351⁷	7%	$360,990	$375,253	$1,028
semaglutideWegovy®	Not published	Withheld	n/a	Not published	Not published	Not published
semaglutideOzempic®	Fee-for-service	3,498¹⁹	69%	$3,300,519	$3,374,555	$944
semaglutideRybelsus®	Fee-for-service	275²⁵	5%	$276,964	$277,816	$1,007
liraglutideSaxenda®	Not published	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Fee-for-service	Withheld	n/a	Not published	Not published	Not published
liraglutideliraglutide (generic)	Fee-for-service	at least 59⁴³	1%	$26,428	$26,428	$448

Every published claim in this record came through fee-for-service, meaning the program paid the pharmacy directly. This record shows no managed-care claims for these products. That is a fact about how the file reports, and it points at who to ask: the program.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were higher in 2026Q1 than in 2021Q1: 275 against 64. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 25.5 to 26.1 prescriptions per thousand people enrolled in Alaska Medicaid, on an average of 198,822 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 9 of the 168 product-quarters it holds a row for here, which is 5 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic® and Rybelsus® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Alaska Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Alaska Medicaid paid for each product, quarter by quarter

Prescriptions Alaska Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	at least 40 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$42,056 paid	at least 195 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$199,759 paid	at least 365 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$381,733 paid	at least 705 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$732,439 paid	880 paid prescriptions in the quarter (2026Q1)¹Count$925,080 paid
tirzepatideMounjaro®range 199 to 522	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹¹Withheld4 of 4 product codes withheld	at least 66 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$57,259 paid	at least 129 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$127,924 paid	199 paid prescriptions in the quarter (2023Q2)¹⁰Count$195,848 paid	222 paid prescriptions in the quarter (2023Q3)¹⁰Count$211,773 paid	272 paid prescriptions in the quarter (2023Q4)¹⁰Count$259,980 paid	324 paid prescriptions in the quarter (2024Q1)⁹Count$323,852 paid	385 paid prescriptions in the quarter (2024Q2)⁹Count$371,154 paid	468 paid prescriptions in the quarter (2024Q3)⁹Count$468,708 paid	522 paid prescriptions in the quarter (2024Q4)⁹Count$527,817 paid	517 paid prescriptions in the quarter (2025Q1)⁸Count$521,482 paid	483 paid prescriptions in the quarter (2025Q2)⁸Count$485,048 paid	at least 404 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$418,000 paid	at least 450 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$457,971 paid	351 paid prescriptions in the quarter (2026Q1)⁷Count$360,990 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter¹⁴No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter¹⁴No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter¹⁴No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter¹⁴No row	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable¹³Withheld5 of 5 product codes withheld
semaglutideOzempic®range 1,010 to 4,839	at least 872 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$731,226 paid	1,010 paid prescriptions in the quarter (2021Q2)²⁴Count$880,966 paid	1,277 paid prescriptions in the quarter (2021Q3)²⁴Count$1,088,353 paid	at least 1,509 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$1,276,641 paid	2,113 paid prescriptions in the quarter (2022Q1)²³Count$1,860,973 paid	2,669 paid prescriptions in the quarter (2022Q2)²³Count$2,383,857 paid	3,145 paid prescriptions in the quarter (2022Q3)²³Count$2,836,440 paid	at least 3,315 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$2,950,423 paid	3,796 paid prescriptions in the quarter (2023Q1)²²Count$3,434,900 paid	4,758 paid prescriptions in the quarter (2023Q2)²²Count$4,184,766 paid	at least 4,433 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$3,834,082 paid	at least 4,103 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$3,565,305 paid	4,263 paid prescriptions in the quarter (2024Q1)²¹Count$3,808,332 paid	4,839 paid prescriptions in the quarter (2024Q2)²¹Count$4,326,589 paid	4,714 paid prescriptions in the quarter (2024Q3)²¹Count$4,222,796 paid	at least 5,464 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$4,898,622 paid	at least 4,441 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$4,087,140 paid	at least 4,404 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$4,086,521 paid	at least 2,694 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$2,537,095 paid	at least 5,411 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$4,948,500 paid	3,498 paid prescriptions in the quarter (2026Q1)¹⁹Count$3,300,519 paid
semaglutideRybelsus®range 56 to 422	64 paid prescriptions in the quarter (2021Q1)³⁰Count$48,161 paid	56 paid prescriptions in the quarter (2021Q2)³⁰Count$45,464 paid	74 paid prescriptions in the quarter (2021Q3)³⁰Count$61,967 paid	at least 73 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$62,316 paid	at least 131 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$133,082 paid	at least 168 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$161,495 paid	at least 200 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$204,584 paid	at least 245 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$254,611 paid	at least 369 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$388,042 paid	at least 350 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$331,349 paid	at least 327 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$287,311 paid	336 paid prescriptions in the quarter (2023Q4)²⁸Count$293,264 paid	372 paid prescriptions in the quarter (2024Q1)²⁷Count$321,904 paid	377 paid prescriptions in the quarter (2024Q2)²⁷Count$322,754 paid	422 paid prescriptions in the quarter (2024Q3)²⁷Count$370,913 paid	382 paid prescriptions in the quarter (2024Q4)²⁷Count$345,384 paid	at least 293 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$268,338 paid	at least 294 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$275,553 paid	at least 246 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$234,861 paid	at least 369 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$348,395 paid	275 paid prescriptions in the quarter (2026Q1)²⁵Count$276,964 paid
liraglutideSaxenda®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 81 to 574	574 paid prescriptions in the quarter (2021Q1)⁴²Count$516,852 paid	515 paid prescriptions in the quarter (2021Q2)⁴²Count$482,372 paid	525 paid prescriptions in the quarter (2021Q3)⁴²Count$500,450 paid	434 paid prescriptions in the quarter (2021Q4)⁴²Count$423,660 paid	405 paid prescriptions in the quarter (2022Q1)⁴¹Count$401,310 paid	338 paid prescriptions in the quarter (2022Q2)⁴¹Count$364,462 paid	296 paid prescriptions in the quarter (2022Q3)⁴¹Count$321,380 paid	286 paid prescriptions in the quarter (2022Q4)⁴¹Count$287,963 paid	338 paid prescriptions in the quarter (2023Q1)⁴⁰Count$345,143 paid	257 paid prescriptions in the quarter (2023Q2)⁴⁰Count$265,867 paid	238 paid prescriptions in the quarter (2023Q3)⁴⁰Count$222,549 paid	228 paid prescriptions in the quarter (2023Q4)⁴⁰Count$213,818 paid	213 paid prescriptions in the quarter (2024Q1)³⁹Count$151,324 paid	186 paid prescriptions in the quarter (2024Q2)³⁹Count$125,066 paid	81 paid prescriptions in the quarter (2024Q3)³⁹Count$51,995 paid	at least 101 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³⁹At least$65,992 paid	at least 12 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$8,648 paid	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³⁸Withheld3 of 3 product codes withheld	at least 14 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld³⁸At least$10,045 paid	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³⁷Withheld2 of 2 product codes withheld
liraglutideliraglutide (generic)range 77 to 89	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	89 paid prescriptions in the quarter (2024Q3)⁴⁵Count$57,456 paid	77 paid prescriptions in the quarter (2024Q4)⁴⁵Count$46,177 paid	at least 111 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$64,003 paid	at least 93 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$54,182 paid	at least 40 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$17,782 paid	at least 115 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$53,457 paid	at least 59 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$26,428 paid

What this page cannot tell you

Whether Alaska Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Alaska in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, AK
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state AK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AK", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "249"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, AK
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state AK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "179"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, AK
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state AK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like ZEPBOUND%, state AK, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, AK
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state AK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like ZEPBOUND%, state AK, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, AK
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state AK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like ZEPBOUND%, state AK, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, AK
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state AK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like ZEPBOUND%, state AK, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, AK
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state AK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AK", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "83"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, AK
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state AK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2025", "quarter": "2", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "104"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, AK
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state AK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "118"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, AK
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state AK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "74"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, AK
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state AK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "37"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, AK
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state AK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like MOUNJARO%, state AK, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, AK
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state AK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AK", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, AK
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state AK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like WEGOVY%, state AK, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, AK
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state AK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like WEGOVY%, state AK, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, AK
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state AK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like WEGOVY%, state AK, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, AK
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state AK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like WEGOVY%, state AK, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, AK
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state AK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like WEGOVY%, state AK, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, AK
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state AK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AK", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1398"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, AK
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state AK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "2151"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, AK
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state AK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1930"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, AK
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state AK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1862"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, AK
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state AK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1544"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, AK
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state AK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "804"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, AK
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state AK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AK", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "146"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, AK
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state AK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "177"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, AK
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state AK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "194"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, AK
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state AK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2023", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "150"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, AK
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state AK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "101"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, AK
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state AK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "41"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, AK
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state AK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like SAXENDA%, state AK, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, AK
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state AK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like SAXENDA%, state AK, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, AK
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state AK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like SAXENDA%, state AK, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, AK
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state AK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like SAXENDA%, state AK, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, AK
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state AK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, AK
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state AK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like SAXENDA%, state AK, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, AK
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state AK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AK", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 2-", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, AK
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state AK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "14"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, AK
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state AK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "139"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, AK
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state AK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2023", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "215"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, AK
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state AK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2022", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "260"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, AK
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state AK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2021", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "354"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, AK
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state AK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "AK", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "31"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, AK
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state AK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "55"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, AK
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state AK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "57"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, AK
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state AK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like LIRAGLUTID%, state AK, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, AK
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state AK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like LIRAGLUTID%, state AK, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, AK
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state AK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "AK", "product_name": "product_name like LIRAGLUTID%, state AK, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 30 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 18 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Alaska Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.